Teva Pharmaceutical Industries (TEVA) Price to Sales (2009 - 2026)
Teva Pharmaceutical Industries' Price to Sales was 2.68 in Q3 2026, up 93.9% from 1.38 a year earlier and up 17.5% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Price to Sales (2009 - 2026) Analysis & Trends
For FY2025, Price to Sales at Teva Pharmaceutical Industries came in at 2.35, up 47.1% from FY2024.
- Price to Sales has now increased for four consecutive years.
- In earlier years, Price to Sales was 1.60 in FY2024 (+102.2%), 0.79 in FY2023 (+7.8%), 0.73 in FY2022 (+21.1%) and 0.61 in FY2021 (-12.9%).
- The Q3 2026 figure marks the highest quarterly Price to Sales since Q1 2016.
- Compared with a year earlier, Price to Sales has increased for 14 straight quarters, with growth averaging 56.6% over the last eight quarters.
- The best year-over-year quarter for Price to Sales over five years was Q4 2024 (growth of 102.2%); the worst was Q2 2022 (a decline of 19.1%).
- Per Business Quant data, TEVA's Price to Sales in the three quarters before Q3 2026 was 2.28 (Q2 2026), 2.02 (Q1 2026) and 2.35 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Teva Pharmaceutical Industries | 49.58 Bn | 34.55 Bn | 2.44 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.68 |
| Jun 30, 2026 | 2.28 |
| Mar 31, 2026 | 2.02 |
| Dec 31, 2025 | 2.35 |
| Sep 30, 2025 | 1.38 |
| Jun 30, 2025 | 1.16 |
| Mar 31, 2025 | 1.06 |
| Dec 31, 2024 | 1.60 |
| Sep 30, 2024 | 1.22 |
| Jun 30, 2024 | 1.13 |
| Mar 31, 2024 | 1.00 |
| Dec 31, 2023 | 0.79 |
| Sep 30, 2023 | 0.75 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | 0.66 |
| Dec 31, 2022 | 0.73 |
| Sep 30, 2022 | 0.59 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.67 |
| Dec 31, 2021 | 0.61 |
API Access
Teva Pharmaceutical Industries Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();